Insect Repellent Testing: Methods, Active Ingredients, and Regulatory Standards

Updated April 30, 2026 to include recent standards and an expanded EPA-registered active ingredients list.

Introduction: Why Insect Repellent Testing Is Critical for Public Health

Insect repellents are among the most globally important personal protection technologies for public health. They form the first line of defense against the mosquito-borne and tick-borne diseases that collectively affect hundreds of millions of people annually. The WHO estimates there were 249 million malaria cases in 2023; dengue infects approximately 400 million people per year; Lyme disease accounts for an estimated 476,000 cases per year in the United States alone; and vector-borne diseases including Zika, chikungunya, West Nile virus, Rocky Mountain spotted fever, and leishmaniasis are expanding geographically as climate change extends the ranges of Aedes aegypti, Aedes albopictus, and tick species into previously non-endemic regions.

Given this public health importance, insect repellent testing is both commercially significant and extensively regulated. In the United States, skin-applied repellents are classified as pesticides under FIFRA (Federal Insecticide, Fungicide, and Rodenticide Act) — not cosmetics — and require EPA pre-market registration supported by efficacy and safety data packages. In the EU, they fall under the Biocidal Products Regulation (BPR, Regulation (EU) 528/2012) as Product Type 19 repellents. Testing laboratories must demonstrate product efficacy against target insect species, characterize the duration of protection, and generate the toxicological safety profile required for regulatory approval.

ContractLaboratory.com connects insect repellent manufacturers, formulators, and importers with accredited consumer goods testing laboratories and toxicology and biocompatibility testing specialists for efficacy, safety, and regulatory compliance testing. See also our guides to EPA pesticide testing requirements and the critical role of a pesticide testing laboratory.

EPA-Registered Active Ingredients in Insect Repellents

The most important dimension missing from most insect repellent testing guides is an explanation of what active ingredients are actually tested. The EPA maintains a list of registered active ingredients for skin-applied repellents. Understanding these actives is essential because testing protocols (concentration of use, duration claims, target insects) differ between active ingredient classes, and the regulatory data requirements for each ingredient vary.

Active ingredient	Chemical name / source	Typical use conc.	Target insects	Notes / CDC status
DEET	N,N-diethyl-m-toluamide (N,N-diethyl-3-methyl-benzamide)	5–100%; typically 20–30% for adults	Mosquitoes, ticks, flies, fleas	Most extensively tested repellent. EPA-registered since 1957. CDC-recommended. Not for children <2 months. Products >30% not needed for more protection. Safe as directed.
Picaridin (Icaridin / KBR 3023)	2-[2-hydroxyethyl]-1-piperidinecarboxylic acid 1-methylpropyl ester	5–20%; 20% for tick protection	Mosquitoes, ticks, flies	Chemical name/source
IR3535	3-[N-butyl-N-acetyl]-aminopropionic acid, ethyl ester (synthetic amino acid derivative; Merck)	10–20%	Leading DEET alternative. No odor, non-greasy, does not damage plastics or synthetics. CDC-recommended. Comparable efficacy to DEET at the same concentration.	CDC-recommended. Developed and widely used in Europe for decades before US registration. Lower neurotoxicity profile than DEET in preclinical models.
OLE / PMD	Oil of Lemon Eucalyptus (plant-derived); PMD = para-menthane-3,8-diol (synthesized version of OLE)	30–40%	Mosquitoes; limited tick data	CDC-recommended. NOT for children <3 years (risk of allergic skin reactions). ‘Pure’ lemon eucalyptus essential oil is not the same as OLE — it is not EPA-registered and has not undergone validated safety/efficacy testing.
2-Undecanone	Naturally derived from wild tomato (Lycopersicon hirsutum) plant trichomes	7.75%	Mosquitoes, ticks	CDC-recognized. Less protection duration data than DEET or picaridin. Produced commercially by BioUD.
Permethrin	Synthetic pyrethroid (3-phenoxybenzyl (1RS)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane-1-carboxylate)	0.5% for consumer clothing; up to 0.5% factory-treated	Mosquitoes, ticks, chiggers (contact insecticide)	CLOTHING ONLY — never apply to skin. Contact insecticide/repellent; kills insects on contact with treated fabric. Factory-treated: 70+ wash durability. Consumer-applied: 5-6 washes.

Important note on natural/unregistered repellents: Products containing plant essential oils such as citronella, lemongrass, eucalyptus, peppermint, or soybean oil as active ingredients are generally not EPA-registered for repellent efficacy claims. Unregistered products cannot make label claims about specific pests or the duration of protection. These products are typically less effective and require more frequent reapplication than registered actives. The EU BPR equally requires authorized active substances; making repellent claims without active substance approval is prohibited.

Types of Products Requiring Insect Repellent Testing

• Skin-applied liquid sprays and pump sprays: The most common commercial form. Tested for repellent efficacy per EPA OPPTS 810.3700 and WHO guidelines. Concentration and formulation affect efficacy duration and skin absorption.
• Skin-applied lotions, creams, and gels: Common for children’s products and sensitive skin applications. Lower concentration products (typically ≤10–15%) require testing for formulation-specific efficacy — a lotion matrix may slow evaporation and extend duration relative to spray formulations at equivalent concentration.
• Aerosol products: Require additional testing for inhalation exposure assessment — inhalation risk profiling is part of the FIFRA registration data package for aerosol-format repellents.
• Wearable devices (bracelets, clip-ons, patches): Release repellent vapors from a substrate. Testing assesses: active ingredient emission rate (mg/hour); spatial repellency at defined distances; and durability of vapor release over the labeled use period. These products typically have significantly lower efficacy than skin-applied repellents — the area of effective protection is limited.
• Clothing treated with permethrin: Tested for insecticidal efficacy before and after laundering (wash durability). Factory-treated clothing (field uniforms, outdoor apparel brands) undergoes extensive wash durability testing — EPA-registered factory treatments must maintain efficacy for a specified number of wash cycles (typically 70+ for military applications, 20-70 for consumer products).
• Impregnated and treated products (bed nets, tents, gear): WHO Pesticide Evaluation Scheme (WHOPES) / WHO Vector Control Pre-qualification Program evaluates insecticide-treated nets and equipment. ASTM-based methods assess long-lasting insecticidal net (LLIN) efficacy through bioefficacy and wash durability.

Efficacy Testing Methods and Standards

1. Arm-in-Cage Test (Primary Regulatory Efficacy Method)

The arm-in-cage test is the primary method for measuring Complete Protection Time (CPT) and is the basis of the EPA’s OPPTS 810.3700 guideline and the WHO Guidelines for Efficacy Testing of Mosquito Repellents for Human Skin (WHO/HTM/NTD/WHOPES/2009.4). In this method, a volunteer’s forearm is treated with a standardized amount of the test repellent (typically 1 g/600 cm² for the WHO protocol; 2 mL for OPPTS 810.3700). The treated arm is then inserted into a cage containing a minimum of 200 hungry female mosquitoes (most commonly

Aedes aegypti for tropical disease contexts or Aedes albopictus for temperate testing; Anopheles gambiae for malaria-relevant testing. The test is performed at one-hour intervals after application.

• Complete Protection Time (CPT): The duration from repellent application until the volunteer receives the first confirmed bite during a defined 3-minute exposure period. CPT is the primary regulatory endpoint — products must demonstrate CPT appropriate to their labeled duration claim. A typical regulatory standard for full protection is defined as two or fewer bites per 3-minute exposure on each of two successive tests.
• Protection Efficacy (PE%): A complementary quantitative metric calculated as: PE% = [(control landing rate − treated landing rate) / control landing rate] × 100. The control arm (vehicle-treated without active, or untreated skin) provides the baseline landing/biting rate. PE% quantifies the percentage reduction in insect exposure attributable to the active ingredient. Regulatory submissions typically require both CPT and PE% data.

Human volunteer safety and ethical framework: Both EPA and WHO protocols require volunteer recruitment with informed consent, ethics committee/IRB approval, and exclusion criteria for pregnant women, children, and individuals with skin conditions or repellent hypersensitivity. Volunteers are protected from bites by mesh barriers between tests, and maximum exposure levels per protocol session are specified.

2. Cage Tests (Laboratory Screening and Mechanism Studies)

• Spatial repellency: Evaluates whether a repellent device, treated surface, or vapor source prevents insects from entering a defined space. A treated surface or device is placed in one section of a divided cage; the distribution of insects between treated and control compartments is recorded after a defined exposure period. Used to characterize wearable device efficacy and spatial repellent products.
• Landing and biting inhibition: A treated surface (mimicking treated skin or fabric) is exposed to a specified number of insects. Landing rate and biting rate on the treated surface are compared to an untreated control to calculate PE%. This laboratory method screens formulations before human volunteer testing.
• Knockdown and lethality: For permethrin-treated textiles and treated nets, cone bioassays and WHO cone tests assess insecticidal activity — the time to knockdown and mortality of insects forced to rest on treated fabric.

3. In-Use and Field Testing

Laboratory cage and arm-in-cage tests provide controlled efficacy data but do not replicate the variable conditions of real-world use — ambient temperature (affects volatilization rate), humidity, physical activity (sweat, dilution), UV exposure (photodegradation), and incidental contact with water (swimming, rain). Field testing and in-use studies expose treated volunteers to natural insect populations in endemic or highly populated environments, providing ecologically valid efficacy data that complements controlled laboratory studies. Field testing is particularly important for establishing realistic duration claims under actual-use conditions.

Regulatory Frameworks for Insect Repellent Testing

United States: EPA FIFRA Registration

In the United States, skin-applied insect repellents are regulated as pesticides under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) — not as cosmetics or OTC drugs. This classification means that every product making repellent claims against insects must be registered with the EPA before commercial sale. The pesticide registration process under FIFRA Section 3 requires submission of:

• Efficacy data (OPPTS 810.3700): EPA Product Performance Test Guidelines OPPTS 810.3700 defines the efficacy testing requirements for insect repellents. Arm-in-cage tests using target insect species are required, with specific protocols for mosquitoes (Aedes aegypti and other species), ticks, and other arthropods for which protection is claimed. CPT and PE% data must support any duration claims on the label.
• Toxicology data package: A tiered series of GLP toxicology studies including acute oral toxicity (OECD TG 401/423/425), acute dermal toxicity (OECD TG 402), acute inhalation toxicity (OECD TG 403 — particularly critical for aerosol products), primary dermal irritation (OECD TG 404), eye irritation (OECD TG 405), skin sensitization (OECD TG 406 Buehler test or 429/442C/D/E for LLNA/h-CLAT), subchronic (28-day, OECD TG 407 or 90-day OECD TG 408), chronic toxicity, reproductive toxicity, and mutagenicity (OECD TG 471 Ames test).
• Product chemistry data: Identity, physical/chemical properties, analytical method for active ingredient quantification, stability data (including shelf-life studies under CIPAC MT 75.3 accelerated storage conditions).
• Environmental fate and ecotoxicology: As EPA-regulated pesticides, repellents require environmental fate data (soil, water, air degradation) and ecotoxicology testing (aquatic organisms, birds, beneficial insects).

Products containing already-registered active ingredients (DEET, picaridin, IR3535, OLE/PMD, 2-undecanone) may qualify for registration under a “reduced risk” pathway or by relying on existing efficacy and toxicology data for the active substance, while still submitting product-specific efficacy data for the specific formulation. New active ingredients require a complete data package.

European Union: Biocidal Products Regulation (BPR) — Product Type 19

In the EU, insect repellents are regulated as biocidal products under Regulation (EU) 528/2012 (the Biocidal Products Regulation, BPR), in force since September 1, 2013. Skin-applied insect repellents fall under Product Type 19 (Repellents and Attractants) — biocidal products used to repel or attract harmful organisms (insects, arachnids, vertebrates, fish, mollusks) for control purposes, including repellents applied to human or animal skin or clothing.

The BPR operates a two-tier system:

• Tier 1 — Active substance approval at EU level: Each active substance must be evaluated and approved by ECHA before products containing it can be authorized. Approval requires submission of a comprehensive dossier covering toxicology, ecotoxicology, environmental fate, efficacy, and analytical methods. Active substance approval is time-limited (typically 5–10 years) and subject to periodic renewal.
• Tier 2 — Product authorization (national or Union): Once the active substance is approved, individual products (specific formulations with specific concentrations, formats, and label claims) must be authorized either nationally by a member state competent authority or through a Union authorization procedure (EU-wide market access in a single application). Product dossiers must include efficacy data, product-specific toxicology (if formulation contains co-formulants with toxicological significance), and physical/chemical data.
• Treated articles: Permethrin-treated clothing and other articles treated with biocidal products fall under BPR treated article provisions. Such articles may only contain active substances approved under BPR. Manufacturers must label treated articles when biocidal property claims are made and provide product information to consumers on request within 45 days.

WHO WHOPES / Vector Control Prequalification

The WHO Pesticide Evaluation Scheme (WHOPES), now integrated into the WHO Prequalification of Vector Control Products (WHO PQ VCP) program, provides international efficacy and safety evaluations for insecticides and repellents used in public health vector control. WHO prequalification is required for products procured by UNICEF, Global Fund, and other international health organizations for malaria control programs. The WHO has published specific guidelines: Guidelines for Efficacy Testing of Mosquito Repellents for Human Skin (WHO/HTM/NTD/WHOPES/2009.4), which specifies arm-in-cage test protocols, human landing collection methods for field testing, statistical requirements, and acceptance criteria for CPT and PE% results.

Key Efficacy Testing Standards

• EPA OPPTS 810.3700: Product performance test guideline for insect repellents on human skin. Defines arm-in-cage test protocol, target species, application rates, and CPT measurement. Part of the EPA FIFRA registration efficacy data package.
• ASTM E939: Standard practice for laboratory bioassay for efficacy of repellents against mosquitoes. Used for screening and comparative testing of formulations.
• ASTM E951-94 (reapproved 2016): Standard method for laboratory testing of non-commercial insect-repellent formulations on the skin. Useful for research and pre-registration screening.
• WHO Guidelines for Efficacy Testing (WHO/HTM/NTD/WHOPES/2009.4): The principal international protocol for mosquito repellent efficacy testing, specifying arm-in-cage and field test methods, statistical requirements, and evaluation criteria.
• CIPAC MT 75.3: Provides guidelines for testing the physical and chemical stability of pesticide formulations stored under elevated temperature and humidity conditions — applicable to stability testing of repellent formulations for shelf-life determination.

Permethrin-Treated Clothing and Textiles: Specialized Testing Requirements

Permethrin stands apart from the other repellents in this guide because it is a contact insecticide, not a skin-applied repellent. Permethrin binds tightly to fabric fibers and kills or incapacitates insects that land on treated clothing — it does not repel them at a distance. It must never be applied to the skin. This fundamental difference means that permethrin-treated clothing requires a specialized testing protocol focused on three parameters:

• Initial efficacy (contact bioassay): Cone bioassays or similar contact tests expose mosquitoes, ticks, or other target arthropods to treated fabric for defined periods. Knockdown rate (incapacitation within a time window) and mortality (at 24 hours post-exposure) are measured. Factory-treated clothing is tested before sale; consumer-applied products are tested after application and drying.
• Wash durability (retention of efficacy): The most commercially important parameter for treated clothing. Fabric samples are subjected to standardized laundering cycles (AATCC 135 or equivalent) and re-tested by contact bioassay after specified numbers of washes. EPA-registered factory-treated military uniform fabric must maintain measurable efficacy for 70+ wash cycles. Consumer retail outdoor apparel typically claims 20–70 washes. Permethrin concentration remaining in fabric after washing is quantified by GC-MS or HPLC following solvent extraction.
• Skin exposure/dermal absorption assessment: Although permethrin is not applied to skin intentionally, migration from treated fabric to underlying skin is possible during wear. Dermal absorption studies assess the extent of permethrin transfer from fabric to skin under simulated wearing conditions, supporting the safety characterization required for EPA registration of treated article claims.

Factory-treated permethrin clothing products (such as Insect Shield and ExOfficio Bugs Away) undergo EPA registration as treated articles under FIFRA. Consumer products for field application (sprays/solutions for treating clothing) are registered as conventional pesticide products requiring a complete FIFRA efficacy and toxicology data package.

Safety Testing for Insect Repellents

Insect repellents have unique safety testing requirements compared to most consumer products because they are applied directly to skin — often repeatedly and over extended periods, including on children. The safety data package for EPA FIFRA registration or EU BPR active substance approval encompasses the following studies, all conducted under Good Laboratory Practice (GLP) conditions and following OECD test guidelines:

Skin Safety Testing

• Acute dermal irritation/corrosion (OECD TG 404): Single semi-occlusive application to skin, assessed at 24/48/72 hours. Identifies potential for skin irritation or corrosion from the formulation.
• Skin sensitization — Buehler test (OECD TG 406) or LLNA/in vitro alternatives (OECD TG 429, 442C/D/E): Identifies potential for delayed hypersensitivity reactions (allergic contact dermatitis). The Local Lymph Node Assay (LLNA, OECD 429) and in vitro alternatives (h-CLAT, KeratinoSens, ARE-Nrf2) are increasingly used as replacements for the Buehler guinea pig test, consistent with the EU’s drive to reduce animal testing. Patch testing in human volunteers and the Repeated Insult Patch Test (RIPT) provide clinical human sensitization data.
• Eye irritation (OECD TG 405) or in vitro alternatives (OECD TG 437, 438, 460): Required given the risk of aerosol or lotion product contact with eyes.
• Human repeat insult patch test (RIPT): Multiple sequential inductions (typically 9 induction applications) followed by a challenge application 2 weeks later on a naive skin site. Detects delayed-type hypersensitivity in human volunteers. A key pre-market safety study for skin-applied products.

Systemic Toxicology Studies

• Acute oral toxicity (OECD TG 420 Fixed Dose, 423 Acute Toxic Class, or 425 Up-and-Down): Assesses single-dose oral hazard — critical for accidental ingestion risk assessment, particularly for children.
• Acute inhalation toxicity (OECD TG 403): Particularly important for aerosol-format repellents. Headspace concentration measurements during product use supplement inhalation toxicity data.
• Subchronic/chronic toxicity (OECD TG 407 — 28-day; OECD TG 408 — 90-day; OECD TG 452/453 — chronic/carcinogenicity): Repeated exposure studies revealing cumulative effects and identifying no-observed-adverse-effect levels (NOAELs) for risk assessment. NOAELs from these studies feed into the safety margin calculations for label directions.
• Reproductive and developmental toxicity (OECD TG 421/422 combined, 414 prenatal dev. tox., 416 two-generation): Critical for products used by pregnant women and products with children on the label. DEET developmental toxicity studies supported its safe use in pregnancy when applied as directed.
• Neurotoxicity (OECD TG 424 — acute neurotoxicity; 418/419 — repeated dose): Required for DEET and other actives given historical concern about neurological effects; modern DEET studies support safety at registered concentrations.
• Mutagenicity/genotoxicity (OECD TG 471 — Ames test; OECD TG 473 — in vitro chromosome aberration; OECD TG 487 — in vitro micronucleus): Standard genotoxicity battery required for EPA and BPR registration.

Finding Accredited Insect Repellent Testing Laboratories

Insect repellent testing requires laboratories with specific biological testing capabilities (insect colonies of target species maintained under controlled conditions per WHO/EPA protocols), GLP-compliant toxicology facilities, and analytical chemistry capabilities for active ingredient quantification (GC-MS, HPLC) and formulation characterization. For EPA FIFRA registration submissions, toxicology studies must be conducted under EPA GLP (40 CFR Part 792). For EU BPR submissions, OECD GLP compliance is required.

ContractLaboratory.com connects insect repellent manufacturers, formulators, brands, and importers with accredited consumer goods testing laboratories and toxicology and biocompatibility testing specialists. See also our resources on toxicity testing, EPA pesticide testing requirements, pesticide testing laboratories, and cosmetics and personal care testing.

Frequently Asked Questions About Insect Repellent Testing

Conclusion

Insect repellent testing is a specialized regulatory and scientific discipline driven by the global public health importance of protecting people from mosquito-borne and tick-borne diseases. The testing framework spans active ingredient characterization (DEET, picaridin, IR3535, OLE/PMD, permethrin), efficacy demonstration through arm-in-cage Complete Protection Time testing and Protection Efficacy measurement, safety substantiation through GLP OECD toxicology studies, and regulatory compliance under EPA FIFRA (US pesticide registration) and EU BPR Product Type 19 (EU biocidal product authorization). The factual basis of every label claim — protection duration, target insects, number of wash cycles for treated clothing — must be supported by laboratory data generated in compliance with EPA, WHO, and OECD guidelines before a product reaches consumers.

ContractLaboratory.com connects insect repellent manufacturers, brands, and importers with accredited consumer goods testing laboratories for efficacy, safety, and regulatory compliance testing. Submit a testing request or contact our team.